Magsoothium Body Cooling Formula

Description

Magsoothium CBD Cooling Formula is a homeopathic pain reliever formulated as a body cream. This product is designed to help relieve minor aches and pains. It is presented in a net content of 4 oz (112 ml).

Uses and Indications

This drug is indicated as a homeopathic pain reliever for the alleviation of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the product should be applied directly onto the affected area. There is no requirement to rub, massage, or bandage the area after application. The application may be repeated as necessary; however, it is important not to exceed a maximum of four applications per day.

For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

There are no specific contraindications associated with this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

The product is intended for external use only. It is imperative that healthcare professionals advise patients to use this product strictly as directed. Bandaging or covering the treated area is contraindicated, as is the application of ice or heating pads in conjunction with this product. Additionally, the use of this product with any medical device or other topical treatments is not recommended.

Healthcare professionals should caution patients to avoid contact with the eyes and mucous membranes. The product should not be applied to wounds or damaged skin. Pregnant or breastfeeding individuals are advised to consult a healthcare professional prior to use.

General precautions include keeping the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

No specific laboratory tests are required for monitoring the safe use of this product. However, healthcare professionals should remain vigilant and provide appropriate guidance to ensure patient safety.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should be applied strictly as directed. It is crucial not to bandage or cover the area being treated, nor should ice or heating pads be used in conjunction with this product. Additionally, patients should refrain from using this product with any medical device or other topical treatments, as such combinations may lead to adverse effects.

Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury. The product should not be applied to wounds or damaged skin, as this may exacerbate adverse reactions. Furthermore, pregnant or breastfeeding individuals are advised to consult a health professional prior to use to ensure safety for both the mother and child. Adhering to these guidelines is essential for minimizing the risk of adverse reactions associated with the use of this product.

Drug Interactions

The use of this medication is contraindicated in conjunction with any medical device or other devices. Additionally, it should not be combined with any other topical treatments. These restrictions are in place to prevent potential adverse interactions that may compromise the efficacy of the treatment or lead to unforeseen complications. It is essential for healthcare providers to adhere to these guidelines to ensure patient safety and optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Magsoothium Body Cooling Formula (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication directly onto the affected area without the need for rubbing, massaging, or bandaging. The application may be repeated as necessary, but should not exceed four times daily. For children under 2 years of age, consultation with a physician is recommended prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies tailored to the individual case.

Overall, vigilance and prompt intervention are critical in managing overdose situations effectively.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with accidental ingestion. In such cases, patients should be instructed to seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of both patients and their families.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to protect the contents from light exposure, which can compromise the product's efficacy. Additionally, it is important to discard the product after opening to ensure safety and effectiveness.

Additional Clinical Information

Patients should apply the medication directly onto the affected area without the need for rubbing, massaging, or bandaging. The application may be repeated as necessary, but it should not exceed four times daily.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately in the event of accidental ingestion. Patients are advised to discontinue use and consult a doctor if their condition worsens, symptoms persist for more than seven days, or if redness or irritation develops. Additionally, pregnant or breastfeeding patients should consult a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Magsoothium Body Cooling Formula, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)